Monday (29.10.2018)

07:30 – 09:00

Scientific Session Advanced Stages

09:15 – 10:15

Scientific Symposium (by Celgene GmbH) CAR T Cell Therapies: Hype Or Hope?

10:30 – 12:00

Scientific Session Pediatric HL

  • Kara Kelly
  • Christine Mauz-Körholz
  • PD1/-L1 Expression in Pediatric HL

    • Stefan Gattenlöhner
  • Genotyping in Familial HL

    • Jun Yang
  • Functional and Financial outcomes after Treatment for Pediatric Hodgkin Lymphoma

    • Susan Parsons

12:15 – 13:45

Scientific Symposium (by MSD) Checkpointblockade in Lymphomas

14:00 – 15:30

Scientific Session Immunotherapy – Clinical

  • Martin Hutchings
  • Philippe Armand
  • Checkmate 205: Cohort D

    • Stephen Ansell
  • GHSG NIVAHL Phase II Trial

    • Paul Bröckelmann

15:30 – 16:00

Main Program Poster Walk

16:00 – 17:30

Scientific Session Relapsed/Refractory HL

  • Anna Sureda
  • Craig H. Moskowitz
  • Transplant BRaVE : Phase II trial

    • Anton Hagenbeek
  • Novel Agents in First Line Salvage

    • Ranjana Advani

17:30

Main Program Closing Remarks

ISHL11 Preliminary Program

ISHL11 Preliminary Program